Alkem to expand global business through CRO route
Clinical research organisations (CROs) are India’s next big opportunity as more and more multinational companies look towards the country for conducting clinical trials.

Ranbaxy recasts China operations
Domestic pharma company Ranbaxy Laboratories has said that the company was restructuring its Chinese operations.

Glaxo plans clinical trials of malaria vaccine in India
GlaxoSmithKline Pharmaceuticals said that GlaxoSmithKline Biologicals, GKS’s vaccine subsidiary has achieved a breakthrough in malaria vaccine development.

Indoco files draft prospectus for IPO
Indoco Remedies, one of the leading pharmaceutical company with presence in pain management, gynaecology, paediatric, cardiology and diabetology segments, has filed with SEBI, the draft red herring prospectus for its maiden public issue.

Drager Medical drags government to court
Drager Medical AG & Co KgaA has challenged government decision to reject its proposal of setting up a wholly-owned subsidiary on the ground of Press Note 18.

Ranbaxy reports 3.3 per cent de-growth in sales
Ranbaxy Laboratories (RLL) results for 3QCY04 were affected by slower domestic growth and drop in exports, stated a release.